xmlns:atom="http://www.w3.org/2005/Atom"

Explanatory Note

(This note is not part of the Order)

This Order brings into force on 21 May 2010 provisions of the Health and Social Care Act 2008 (“the Act”) relating to the funding of expenditure on community pharmaceutical services provided as part of the National Health Service in Wales. The principal changes are: firstly, that funding for community pharmaceutical services that previously had been held centrally will become part of the allocations given to Local Health Boards; and secondly, the Welsh Ministers are given powers to designate any element of the remuneration paid by Local Health Boards for community pharmaceutical services which is not referable to the cost of drugs. Designation is a mechanism which allows the Welsh Ministers to control the way the funding of a designated element is apportioned between Local Health Boards.